Blog Posts

Fumiko Ladd Chino: Advocacy as a Tool for Cancer Care Progress

Fumiko Ladd Chino/X

Aug 7, 2025, 11:27

Fumiko Ladd Chino: Advocacy as a Tool for Cancer Care Progress

ASCO (American Society of Clinical Oncology) shared a post on X by Fumiko Ladd Chino, Associate Professor in Radiation Oncology at MD Anderson Cancer Center, adding:

“Thank you Fumiko Ladd Chino for sharing your story and inspiring your patients and fellow ASCO members.
Federal research is paramount to stopping cancer.
Urge your lawmakers to support FY26 funding for NIH and the NCI.

Act now.”

Quoting Fumiko Ladd Chino‘s post:

“We have agency.
We can speak up. We can show up.

Advocating for cancer care means speaking to legislators, bringing patient stories to the front lines of policymakers, supporting and amplifying each other to continue to do the work that changes outcomes.”

More posts featuring Fumiko Ladd Chino and ASCO on OncoDaily.

American Society of Clinical Oncology ASCO cancer cancer care Fumiko Ladd Chino National Cancer Institute National Institutes of Health NCI NIH OncoDaily Oncology

Padraic O’Malley: Meet the Experts of VIRO 2025

Hidden Risks: BRCA Mutations and Breast Implants - CancerWorld

FDA Breakthrough Therapy Designation for Iza-bren: Advancing Treatment for EGFR-Mutant NSCLC

Neil Ranasinghe: What’s the Difference Between a Clinician and a Technical Author?

LOCKTAC Molecular Glues Are Changing the Rules of Drug Discovery - Amgen